Research article; Review; Others (Comments/Perspectives/News&Views)
No
None
Open Submission
EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance.
To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields:
<ol>
Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention).
Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease.
Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI)
</ol>
The journal is one of four EMBO Press journals run by in-house professional scientific editors. EMBO Molecular Medicine is supported by our academic Chief Editor, Prof. Philippe Sansonetti, and our broad and diverse <a href='https://www.embopress.org/page/journal/17574684/editors'>advisory editorial board</a>. Our journal is editorially independent of its publisher Springer Nature. For further details on our relationship to other EMBO Press publications, please see <a href='https://www.embopress.org/page/journal/17574684/authorguide#transferpolicies'>below</a>.
EMBO Molecular Medicine publishes research papers as full-length Articles, short Reports, Methods and Resource articles. In addition, the journal publishes Editorials and Reviews in innovative formats that target a broad and non-specialized audience, as well as News & Views, Opinions and Comments.
Areas covered include, but are not limited to:
Vascular and cardiovascular biology
Infectious diseases and vaccines
Microbiome
Endocrinology and metabolic diseases
Stem cells and regenerative medicine
Systems medicine and clinical genomics
Aging
Neurodegeneration and neurological diseases
Myopathies and musculoskeletal disease
Gene and cell therapy
Human genetics, autoimmunity, and rare diseases
Immunology and inflammation
Oncology
Molecular diagnostics, biomarkers and imaging
Drug discovery
Mitochondrial diseases
Gastroenterology
Nephrology
Respiratory diseases
Reproductive medicine
Biomedical technologies
Human clinical studies
Case reports
Exposome studies
Toxicology